Skip to main content
. 2011 Jun 3;45(2):102–115. doi: 10.2478/v10019-011-0015-6

FIGURE 1.

FIGURE 1.

Prognostic impact of CD133 mRNA level on survival of the patients. CD133 mRNA expression was measured by QRT PCR in glioma samples of 19 patients and compared to their survival time post-operation. Survival of patients with higher CD133 mRNA levels above a cut-off of 30 000 (─, 2−ΔΔCt > 30.000) was significantly shorter (median 81 days) than survival of patients with CD133 mRNA levels below the cut off (─, 2−ΔΔCt < 30.000; median 284 days, p = 0.005).